Marker Therapeutics, Inc.MRKRNASDAQ
Loading
SG&A Expenses Over TimeExpanding
Percentile Rank100
3Y CAGR+7073.6%
5Y CAGR+1219.3%
Studio
Year-over-Year Change

Selling, general, and administrative expenses

3Y CAGR
+7073.6%/yr
vs -17.4%/yr prior
5Y CAGR
+1219.3%/yr
Recent acceleration
Acceleration
+7091.0pp
Accelerating
Percentile
P100
Near historical high
vs 5Y Ago
399618.6x
Strong expansion
Streak
1 yr
Consecutive growthExpanding
PeriodValueYoY Change
TTM$4.18T+98660761.3%
2024$4.24M-43.3%
2023$7.48M-34.1%
2022$11.34M+16.1%
2021$9.76M-6.8%
2020$10.47M+5.0%
2019$9.98M-59.1%
2018$24.38M+280.2%
2017$6.41M+36.7%
2016$4.69M-